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Background: Genome-wide association studies have identified numerous single nucleotide polymorphisms (SNPs)
as associated with colorectal cancer (CRC) risk in populations of European descent. However, their utility for
predicting risk to CRC in Asians remains unknown. A case-cohort study (random sub-cohort N = 1,685) from
the Korean Cancer Prevention Study-II (KCPS-II) (N = 145,842) was used. Twenty-three SNPs identified in previous
47 studies were genotyped on the KCPS-II sub-cohort members. A genetic risk score (GRS) was calculated by summing
the number of risk alleles over all SNPs. Prediction models with or without GRS were evaluated in terms of the area
under the receiver operating characteristic curve (AUROC) and the continuous net reclassification index (NRI).
Results: Seven of 23 SNPs showed significant association with CRC and rectal cancer in Koreans, but not with colon
cancer alone. AUROCs (95% CI) for traditional risk score (TRS) alone and TRS plus GRS were 0.73 (0.69–0.78) and 0.74
(0.70–0.78) for CRC, and 0.71 (0.65–0.77) and 0.74 (0.68–0.79) for rectal cancer, respectively. The NRI (95% CI) for a
prediction model with GRS compared to the model with TRS alone was 0.17 (-0.05-0.37) for CRC and 0.41
(0.10–0.68) for rectal cancer alone.
Conclusion: Our results indicate genetic variants may be useful for predicting risk to CRC in the Koreans,
especially risk for rectal cancer alone. Moreover, this study suggests effective prediction models for colon and
rectal cancer should be developed separately.
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According to the Korean National Cancer Center, the inci-
dence of colorectal cancer (CRC), the 3rd most common
cancer in Korea, has increased from 21.2/100,000 people
in 1999 to 39.0/100,000 people in 2011 [1]. Steady in-
creases in the incidence of CRC should be expected, partly
due to environmental factors such as increased Western
dietary patterns. Early discovery of high-risk groups could
be helpful in managing risk factors and ultimately in redu-
cing CRC incidence and mortality [2].
Previous studies have proposed CRC prediction models
but these attained only limited predictive power [3,4].
Some models reflect only one aspect of the associated risk
factors and failed to incorporate both the genetic and
traditional risk factors (including environmental factors)* Correspondence: jsunha@yuhs.ac
3Institute for Health Promotion and Department of Epidemiology and Health
Promotion, Graduate School of Public Health, Yonsei University, 50 Yonse-ro,
Seodaemun-gu, Seoul, South Korea
Full list of author information is available at the end of the article
© 2015 Jung et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.of CRC [3-5]. Moreover, many previous models did not
distinguish between the colon and rectal cancer, which are
distinct by anatomic sites and other characteristics [2,6].
In fact, previous publications have reported colon and rec-
tal cancer show different associations with traditional risk
factors [7-9]. Therefore, to develop more effective predic-
tion models, we should 1) include information on both
genetic and traditional risk factors, and 2) distinguish be-
tween colon and rectal cancers.
For our CRC predictive model, the most appropriate
traditional risk factors were determined from a prospect-
ive cohort study of the general Korean population. Also,
after incorporating genetic factors into the model, its
utility was carefully evaluated. Our study provides evi-
dence that considering genetic factors as well as trad-
itional risk factors in risk prediction models can improve
their utility.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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We attained 633,210 person-years (PY) after following
145,842 study subjects through December 2012. During
the follow-up period, 258 CRC patients were verified from
the National Cancer Center cancer registry database. Over-
all incidence rate per 100,000 PY was 40.7.
Table 1 shows the characteristics of all study participants.
Participants from the KCPS-II cohort and sub-cohort
had similar characteristics of age, sex, BMI, smoking
status, alcohol drinking, exercise, and family history. In
each cohort, the case group was older and had higher
BMI and fasting blood glucose than did the control group.
Also, in each cohort, the patient group showed higher
rates of smoking and more cases reported a family history
of CRC.
Table 2 shows the estimated hazards ratio (HR) of vari-
ous factors contributing to the risk of CRC. Each cohort
showed similar findings between participants in the whole
KCPS-II cohort and the sub-cohort participants. Age, sex,
fasting serum glucose, smoking status, exercise, and family
history were ultimately selected as predictors for CRC.
Table 3 shows allelic association with CRC, colon, and
rectal cancer, respectively. Depending on the cancer loca-
tion (colon or rectum), each SNP showed a different pat-
tern of association. A total of 5 out of 23 SNPs showed
significant association only with rectal cancer, but not on
colon cancer. A total of 2 out of 23 SNPs showed a posi-
tive association across both colon and rectum cancer, al-
though it was only moderately significant.
In this study, the GRS was based on 7 SNPs (rs3802842,
rs4939827, rs6983267, rs10505477, rs10795668, rs961253,
and rs9929218). Overall these GRS followed a normal dis-
tribution (data not shown).Table 1 General characteristics of study participants: The Korea
KCPS-II cohort (Whole pa
CRC No CRC
N 258 145,584
Age, year 50.7 ± 10.5 41.1 ± 10
Sex, % of female 24.1 37.9
Body mass index, kg/m2 24.3 ± 2.7 23.6 ± 3.2
Fasting blood glucose, mg/dL 99.0 ± 25.3 91.0 ± 19
Total cholesterol, mg/dL 197.7 ± 37.1 189.0 ± 3
Systolic blood pressure, mmHg 123.4 ± 16.3 117.9 ± 1
Smoking status, % Ex 31.0 17.7
Current 29.9 29.2
Alcohol drinking (yes), % 73.6 74.0
Exercise (yes), % 63.2 59.6
Family history of CRC (yes), % 5.0 2.3
Values are mean ± standard deviation (SD) for continuous data.
Body mass index (BMI) = weight in kilograms divided by height in meters squared.
CRC: Colorectal cancer, KCPS-II: The Korean Cancer Prevention Study-II.Table 4 shows the predictive power of models incorp-
orating GRS with TRS for CRC, and rectal cancer using
both the ROC area and NRI. AUROC (95% CI) for TRS
alone was 0.73 (0.69-0.78) for CRC, and 0.71 (0.65–0.77)
for rectal cancer alone. The AUROC (95% CI) for the
combined model with both TRS and GRS was increased,
especially for rectal cancer [0.74 (0.68-0.79)]. NRI (95%
CI) for the model with GRS compared to the model
with only TRS was 0.17 (-0.05–0.37) for CRC, and 0.41
(0.10–0.68) for rectal cancer. Table 4 also shows the risk
of CRC and rectal cancer alone after dividing GRS into
quartiles. Compared with participants in the lowest quar-
tile, those with the highest quartile of GRS had a 2.65-fold
higher risk for CRC and a 10.83-fold higher risk for rectal
cancer alone, respectively.
Figure 1 shows the combined risk of CRC and rectal
cancer separately after dividing each GRS and TRS into
quartiles. As the GRS increased into quartile 4 (Q4), the
CRC risk increased. Also, as the TRS increased in quartile
4 (Q4), the CRC risk increased even more. Participants
with TRS and GRS in the highest quartile (Q4) were deter-
mined to have about 25 times higher risk of CRC than
those with TRS and GRS in the lowest quartile (Q1). Like-
wise, participants with TRS and GRS in the highest quar-
tile (Q4) were determined to have about 40 times as much
risk of rectal cancer compared to those with TRS and GRS
in the lowest quartile (Q1).
Discussion
Gene-based prediction of CRC in literatures
The heritability of risk to CRC is estimated to be ~35%
[10] but only about 5% of CRC cases can be attributable
to highly penetrant mutations in recognized genes.n Cancer Prevention Study-II and the KCPS-II sub-cohort
rticipants) KCPS-II sub-cohort (Case-cohort design)
P CRC No CRC P
173 1,514
.3 <0.001 49.7 ± 10.9 40.1 ± 9.4 <0.001
<0.001 25.0 37.6 0.001
<0.001 24.3 ± 2.7 23.5 ± 3.2 0.001
.0 <0.001 98.2 ± 27.8 90.1 ± 17.9 <0.001
3.8 0.002 195.6 ± 36.9 189.3 ± 41.8 0.037
4.4 <0.001 121.8 ± 14.7 117.6 ± 14.3 0.037
<0.001 29.6 15.8 <0.001
30.7 30.2
0.881 74.4 76.7 0.496
0.228 62.5 61.8 0.850
0.005 5.1 2.0 0.011
Table 2 Hazard ratios for risk factors on risk of CRC: The Korean Cancer Prevention Study-II and the KCPS-II sub-cohort
KCPS-II cohort (Whole participants) KCPS-II sub-cohort (Case-cohort design)
Traditional risk factors HR (95% CI) HR (95% CI)
Age, year 1.07 (1.06-1.08) 1.08 (1.07-1.10)
Sex (female) 0.65 (0.45-0.92) 0.71 (0.50-1.11)
Log (fasting serum glucose), mg/dL 1.81 (0.99-3.30) 2.16 (0.96-4.83)
Smoking status Ex-smoker 1.45 (1.03-2.05) 1.74 (1.12-2.72)
Current smoker 1.28 (0.90-1.83) 1.40 (0.91-2.17)
Exercise (yes) 0.91 (0.70-1.17) 0.68 (0.49-0.94)
Family history of CRC (yes) 2.40 (1.34-4.30) 3.49 (1.70-7.17)
Per 1 SD of TRS increase 1.34 (1.29-1.39) 1.30 (1.24-1.36)
CRC: colorectal cancer, HR: hazard ratios, CI: confidence interval, SD: standard deviation, TRS: traditional risk score,
TRS combined information on above 6 risk factors: age, sex, fasting serum glucose, exercise, and family history of CRC.
KCPS-II: The Korean Cancer Prevention Study-II.
Table 3 Allelic odds ratios for subtype of CRC in the Korean Cancer Prevention Study II sub-cohort
Reference number in
Additional file 2: Table S1
Colorectal cancer Colon cancer Rectal cancer
SNPs* Chr. RA RAF OR (95% CI) OR (95% CI) OR (95% CI)
rs3802842 4,7,19,29,32,34, 36 11 C 0.40 1.46 (1.14-1.86) 1.30 (0.93-1.81) 1.50 (1.10-2.04)
rs4444235 4,7,32,38 14 C 0.52 1.02 (0.80-1.29) 1.01 (0.73-1.40) 1.03 (0.76-1.40)
rs4939827 7,10,29,30,34,41,42,43,44,45,46 18 T 0.22 1.32 (1.01-1.71) 1.04 (0.71-1.52) 1.55 (1.11-2.16)
rs6983267 7,16,17,18,19,20,21,22,23,24,25,26,27,28 8 G 0.43 1.14 (0.91-1.43) 0.85 (0.61-1.17) 1.46 (1.08-1.97)
rs10505477 11,12,13,14,15 8 G 0.43 1.15 (0.92-1.45) 0.88 (0.64-1.21) 1.44 (1.06-1.94)
rs10795668 7,20,30,31,32,33,34 10 G 0.64 1.20 (0.92-1.55) 0.93 (0.66-1.32) 1.45 (1.03-2.05)
rs11169552 1 12 T 0.34 0.98 (0.76-1.25) 1.05 (0.75-1.47) 0.93 (0.67-1.28)
rs6687758 1,2 1 G 0.29 0.96 (0.74-1.25) 1.14 (0.80-1.63) 0.85 (0.60-1.20)
rs7014346 29 8 G 0.69 0.94 (0.73-1.21) 1.08 (0.76-1.54) 0.86 (0.62-1.18)
rs11903757 3 2 T 0.96 0.79 (0.45-1.42) 0.75 (0.35-1.63) 0.91 (0.42-1.96)
rs3217810 3 12 C 0.95 0.98 (0.19-5.21) 0.44 (0.08-2.45) NE
rs10411210 20,28 19 T 0.18 0.91 (0.66-1.25) 0.82 (0.52-1.30) 1.00 (0.67-1.50)
rs961253 4,7,11,19,20,34, 38,47 20 A 0.10 1.38 (0.97-1.97) 1.19 (0.72-1.98) 1.45 (0.93-2.26)
rs6691170 1,2,4 1 T 0.09 NE
rs9929218 20,21,31,38,40 16 A 0.15 1.21 (0.87-1.68) 1.16 (0.74-1.83) 1.20 (0.78-1.82)
rs10911251 3 1 C 0.46 1.01 (0.80-1.29) 0.80 (0.58-1.12) 1.22 (0.90-1.66)
rs7758229 10 6 T 0.22 1.06 (0.80-1.41) 0.91 (0.60-1.37) 1.20 (0.84-1.71)
rs59336 3 12 T 0.63 0.94 (0.73-1.20) 0.79 (0.57-1.12) 1.09 (0.79-1.52)
rs3217901 37 12 G 0.65 1.10 (0.87-1.39) 1.51 (1.08-2.11) 0.83 (0.61-1.12)
rs10936599 1,4,5,6,7,8 3 T 0.61 1.09 (0.87-1.38) 1.07 (0.77-1.48) 1.11 (0.81-1.50)
rs647161 9 5 C 0.69 0.95 (0.73-1.22) 0.72 (0.51-1.01) 1.25 (0.88-1.77)
rs7136702 1 12 T 0.53 1.08 (0.85-1.37) 1.10 (0.79-1.54) 1.02 (0.75-1.39)
rs4779584 4,19,20,30,32,33,36,39 15 T 0.84 0.97 (0.70-1.34) 0.91 (0.58-1.43) 1.02 (0.67-1.55)
CRC: colorectal cancer, Chr.: chromosome, RA: risky allele, RAF: risky allele frequency, OR: odds ratio, CI: confidence interval, NE: not estimated due to small
number, SNP with ORs in bold were selected for genetic risk score calculations.
*List of references and detailed information were summarized in Additional file 2: Table S1.
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Table 4 Area under receiver operating characteristic curve by subtype of CRC: Korean Cancer Prevention Study II
sub-cohort
Colorectal cancer Colon cancer Rectal cancer
HR (95% CI) HR (95% CI)* HR (95% CI) HR (95% CI)* HR (95% CI) HR (95% CI)*
TRS Q1 1.00 1.00 1.00 1.00 1.00 1.00
Q2 1.97 (0.95-4.11) 2.03 (0.98-4.22) 1.60 (0.52-4.94) 1.60 (0.52-4.95) 2.28 (0.87-6.01) 2.40 (0.91-6.31)
Q3 2.57 (1.29-5.14) 2.62 (1.31-5.24) 2.19 (0.76-6.32) 2.16 (0.75-6.24) 2.88 (1.15-7.24) 3.02 (1.20-7.59)
Q4 11.29 (6.06-21.1) 11.54 (6.19-21.5) 13.33 (5.31-33.5) 13.27 (5.29-33.3) 10.16 (4.36-23.7) 10.59 (4.54-24.7)
GRS Q1 1.00 1.00 1.00
Q2 1.42 (0.77-2.61) 0.95 (0.47-1.91) 3.95 (0.93-16.84)
Q3 1.68 (0.92-3.07) 0.77 (0.37-1.59) 7.06 (1.70-29.28)
Q4 2.65 (1.43-4.91) 1.17 (0.55-2.50) 10.83 (2.58-45.40)
AUROC 0.73 (0.69-0.78)† 0.74 (0.70-0.78) 0.76 (0.70-0.83)† 0.75 (0.69-0.81) 0.71 (0.65-0.77)† 0.74 (0.68-0.79)
NRI - 0.17 (-0.05-0.37) −0.17 (-0.33-0.21) - 0.41 (0.10-0.68)
P for NRI 0.108 0.688 0.008
CRC: colorectal cancer, TRS: traditional risk score, GRS: genetic risk score, HR: hazard ratio, CI: confidence interval, AUROC: Area under receiver operating
characteristic curve, NRI: net reclassification index.
*Combined model, †AUROC for TRS alone, AUROC for TRS + GRS.
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identified a number of common genetic markers signifi-
cantly associated with CRC [6,11-13]. However, most of
these GWAS results have been from populations of
European descent. In any GWAS results, the risk associ-
ated with any one marker is individually modest, because
these markers are rarely causal but merely tag regions
haplotypes spanning chromosomal regions. Thus, pre-
dicted risks for individuals tend to be very modest and
rarely exceed thresholds that would trigger any clinical
intervention, and at best these predicted risk might be use-
ful for identifying sub-groups of high-risk subjects carrying
multiple risk alleles. Companies such as DeCODEme and
23andme include panels of common SNPs in their testing
panels and report predicted risk for complex diseases such
as CRC, yet research suggests any prediction based on gen-
etic markers identified through genome-wide studies is of
questionable clinical utility [6].Figure 1 Combined effect of traditional risk score and genetic risk score oPresent study findings
During the follow-up period which included 633,210
person-year coverage, 258 incident CRC cases (196 men
and 62 women) occurred. This case-cohort study evalu-
ated the ability to predict risk based on TRS alone, and
these plus a GRS which aggregates information from 7
genetic markers shown to be associated with risk of CRC
in Koreans. While most genetic epidemiologic studies
have focused on the combined outcome CRC (colon or
rectal cancer), but showed less improvement for CRC and
colon cancer alone in our Korean sub-cohort study. The
rectal cancer prediction model using both TRS and GRS
had an increased AUROC by about 3% compared to the
AUC from a TRS model (Table 4). The prediction model
for rectal cancer alone showed a substantial increase in
NRI of about 41%.
We set out to develop and validate CRC risk predic-
tion models and assess their performance in profilingn colorectal cancer: Korean Cancer Prevention Study-II.
Jung et al. BMC Genetics  (2015) 16:49 Page 5 of 7individual genetic risk of CRC in Koreans. We developed
models incorporating age, gender, fasting serum glucose,
smoking, exercise, family history (FH) and genotype data
from 23 common genetic markers reported to signifi-
cantly associate with CRC in over 47 previous publica-
tions. Several of these 23 SNPs (rs3802842,
rs4939827, rs6983267, rs10795668, rs961263, rs4779584,
and so on) have been well replicated in the scientific litera-
ture (Table 3). In Koreans, 7 SNPs (rs3802842,
rs4939827, rs6983267, rs10505477, rs10795668, rs961263,
rs9929218) among the 23 SNPs were associated with CRC
in our sub-cohort based on 258 incident cases. However,
some of these 7 SNPs showed positive association with
wide 95% confidence intervals.
CRC versus colon and rectal cancer
Previous GWAS using CRC as the outcome (combining
colon and rectal cancer together) reported genome-wide
significant associations between risk and multiple SNPs
[11-13]. But few studies have considered colon and rec-
tal cancer separately. Some studies of environmental fac-
tor argue differences between CRC sub-types may be
important [8-9].
When we separated our CRC cases into colon and rectal
cancer groups, 7 out of 23 reported risk SNPs showed sta-
tistically significant association with CRC and rectal
cancer, but not with colon cancer (Table 3). These SNPs
showed consistent direction of association and effect size,
and the lack of statistical significance could just reflect a
loss of power due to smaller sample sizes.
This suggests future studies should also separate colon
and rectal cancer rather than just testing only the com-
bined outcome CRC. Also, it raises the question of whether
separate prediction models for colon and rectal cancer
should be developed.
TRS versus GRS
In this study of CRC alone, TRS alone showed a strong
predictive power of 0.73, and the addition of a GRS
failed to show significant contribution or change. In the
combined risk models, however, that including both the
TRS and GRS, rectal cancer showed the greatest im-
provement (ROC area change = 3%; NRI = 0.41).
Recently, Dunlop et al. (2013) [6] conducted a ROC
analysis of models including genotype data alone or in
combination age, gender and FH showed very modest
discrimination across the full risk spectrum of risk, with
AUC = 0.59 and 0.57 (internal validation) or 0.56 and
0.57 (external validation sets). Their overall positive pre-
dictive value fell between 0.51 and 0.71.
The modest performance in individualized CRC risk
profiling is consistent with risk prediction studies for other
complex diseases (coronary heart disease [14], stroke
[15,16], and age-related macular degeneration [17]).The best predictive performances have been obtained
by combining genetic, demographic and environmental
variables [17]. In our study, GRS itself showed similar
ROC value (~0.6). However, when we combined GRS with
traditional risk factors (like age, sex, high fasting glucose,
smoking, exercise, and family history) the ROC increased
up to 0.74 for predicting CRC, and similar models for rec-
tal cancer showed greater increase.
Limitation and strength
Major limitations included reliance on self-reported expo-
sures at a single point in time, thus precluding the defini-
tive exclusion of potential misclassification. The statistical
power of the current study is modest, as genotyping was
performed on a limited sample size of CRC cases and con-
trols. A strong point of our study is the case-cohort design
drawn from an underlying large prospective cohort. Case
identifications were performed by record linkage to the
national cancer registry with verification.
Conclusion
In conclusion, findings in this current study provide some
evidence of improved prediction for CRC in models com-
bining traditional and genetic risk factors. This empha-
sizes both genetic and traditional factors associated with
CRC should be considered when predicting risk.
Methods
Study subjects
We have used data on the Korean Metabolic Syndrome
Research Initiative in Seoul, initiated in 2005. We have
labeled this study as the Korean Cancer Prevention
Study-II (KCPS-II). A full description of KCPS-II has
been previously published [9,18]. Study members were
recruited from participants in routine health assessments
at health promotion centers in Seoul and GyeongGi
province, South Korea, between 2004 and 2011. Twenty
one centers holding electronic health records agreed to
linkage of participants’ records to national cancer regis-
try for monitoring of cancer events. The initial study
population included 190,332 individuals (112,852 men,
77,480 women), aged 20-94 years. About 90% of partici-
pants were enrolled between 2005 and 2008, and the
remaining were enrolled prior to or after this period. We
have acquired both written consent forms and blood
samples from 157,526 participants. Among the total
157,526 participants, 174 participants who reported of
having prevalent CRC were excluded. In addition, 11,510
participants who had missing values on body mass index,
fasting blood glucose, total cholesterol, systolic blood
pressure, smoking status, alcohol drinking, and exercise
were excluded. Follow up of participants through Decem-
ber 2011, identified 258 out of these 145,842 participants
as incident cases of colorectal cancer.
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a 1% random sample of all participants. Two of 1,514
randomly selected participants were found to be diag-
nosed with CRC from our sub-cohort study, while 173
CRC cases were verified outside the sub-cohort. In short,
a total of 1,685 additional participants (1,514 plus 173
participants minus 2 participants) were included in our
case-cohort study design. Until 2012, the actual number
of CRC patients eligible for genetic testing was 173 among
all known CRC cases 258. The remaining 85 CRC patients
will be tested during the next phase of our study. The
Institutional Review Board of Yonsei University reviewed
and approved this study.Traditional risk score
To develop the traditional risk score (TRS), Cox propor-
tional hazards regression models were fitted first to a basic
set of classical risk factors: age, sex, smoking status, fasting
serum glucose, family history of colorectal cancer. The
TRS algorithm is given in online Additional file 1.SNP genotyping
Twenty-three single-nucleotide polymorphisms (rs3802842,
rs4444235, rs4939827, rs6983267GG, rs10505477,
rs10795668, rs11169552, rs6687758, rs7014346, rs11903757,
rs3217810, rs10411210, rs961253, rs6691170, rs9929218,
rs10911251, rs7758229, rs59336, rs3217901, rs10936599,
rs647161, rs7136702TT, rs4779584) identified in previous
47 studies were genotyped (Table 3 and Additional file 2:
Table S1). DNA was isolated from peripheral blood of par-
ticipants and genotyped at DNA Link Inc. (Seoul, Korea).
The genotyping was performed using SNP type assay
(Fluidigm, San Francisco, CA, USA) following the manu-
facturer’s recommendation. Genomic DNA flanking these
SNPs of interest was amplified with PCR reaction with
STA primer set and Qiagen 2X Mutiplex PCR Master Mix
(Qiagen) in 5 microliter reaction volume, containing 60 ng
of genomic DNA. PCR reactions were carried out as fol-
lows: 15 min at 95°C for 1 cycle, and 14 cycles on 95°C for
15 s and 60°C for 4 min. After amplification, the the STA
products were diluted 1:100 in DNA Suspension Buffer.
A 2.5 microliter of the diluted STA products were added
to a Sample Pre-Mix containing 3 microliter of 2X Fast
Probe Master Mix, 0.3 microliter of the SNP type 20X
Sample Loading Reagent, 0.1 microliter of the SNP type
Reagent, and 0.036 microliter of the ROX. After the Assay
Pre-Mix and the Sample Pre-Mix were loaded into
the 48.48 Dynamic Array, SNP type assay reaction was
carried out. Analysis was carried out using Fluidigm SNP
Genotyping Analysis software (version 4.0.1; Fluidigm). In-
ternal quality control (QC) measures were employed to
ensure accuracy of the data. A total of 1,685 individuals
were genotyped on this platform.Anthropometric measurements
Each participant was interviewed using a structured ques-
tionnaire to collect information on smoking status and al-
cohol consumption as well as demographic characteristics,
such as age, gender, and family history of various diseases.
Cigarette smoking was classified into never smokers, ex-
smokers, and current smokers. Alcohol consumption was
divided into nondrinkers and current drinkers. Regular
physical activity was tracked as either “yes” or “no”. Par-
ticipant height and weight were measured while the par-
ticipants were wearing light clothing. Body mass index
(BMI) was calculated by dividing the weight (kg) by the
square height (m2). Systolic and diastolic blood pressures
were measured after a rest period of at least 15 min.
SNP selection and GRS calculation
Each SNP in this study was assumed to be associated
with risk following an additive genetic model, which is
considered to be generally robust even when the true
genetic model is not known or may be incorrectly speci-
fied [19]. The GRS was created by two methods: a sim-
ple count method (count GRS) and a weighted method
(weighted GRS) [14,20]. Both methods assumed each
SNP to be independently associated with the risk of CRC
(i.e. no interaction). We assumed an additive genetic
model for each SNP, applying a linear weighting of 0, 1, or
2 to genotypes containing 0, 1, or 2 of the reported risk al-
leles, respectively. This count model assumes each SNP in
the panel contributes equally to the risk for CRC and was
calculated by summing the values for each SNP. The
weighted GRS was calculated by multiplying each esti-
mated beta-coefficient by the number of corresponding
risk alleles (0, 1, or 2).
In this study, traditional risk factor score (TRS) com-
bined information on 6 risk factors: age, sex, fasting
serum glucose, smoking status, exercise status, and fam-
ily history of CRC.
Outcome classification
The principle outcome variable was incidence of CRC
(n = 258 in whole participants, n = 173 in the sub-cohort),
based on data from the national cancer registry. Accord-
ing to the International Classification of Diseases, Tenth
Revision (ICD-10), CRC was coded as C18-C20 (C18 for
colon, C19 for rectosigmoid, and C20 rectum) [21].
Statistical analysis
All statistical tests were two-sided, and statistical signifi-
cance was determined as p<0.05. To evaluate general
characteristics of the study population, means and stand-
ard deviations (SD) were calculated, and frequencies of
cigarette smoking, alcohol consumption, and physical
activity was determined. A χ2 goodness-of-fit test was
used to assess whether SNPs were in Hardy-Weinberg
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quencies between CRC cases and controls. The GRS was
categorized into quartiles. CRC risk associated with any
one genotype was estimated as OR and 95% confidence
interval (CI), and was computed using logistic regression
under an additive genetic model. We also used receiver
operating characteristic (ROC) curve analysis and calcu-
lated the area under the curve (AUC; also known as the C
statistic) and the continuous net reclassification index
(NRI) to evaluate the discrimination power of a CRC risk
model. Finally, Cox proportional hazards models were
used to estimate the effect of GRS and TRS on CRC risk
in our case-cohort design.
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